**Johnson & Johnson Agrees to $5.5 Billion Settlement Over Talc Lawsuits**
Johnson & Johnson (J&J) has reached a significant settlement agreement amounting to $5.5 billion to resolve a multitude of lawsuits in the United States. These lawsuits allege a connection between the company's discontinued talc-based baby powder and ovarian cancer. The announcement was made on July 28, 2026, and the settlement is expected to address approximately 69,000 cases currently pending in both federal and state courts across the country. This figure represents a staggering 99.75 percent of all outstanding talc-related cases in the United States.
Talc, a naturally occurring soft mineral, was once a common ingredient in various cosmetic and personal care products, including baby powder. However, its popularity has waned in recent years due to growing concerns regarding its potential health risks. In 2024, the World Health Organization classified talc as "probably carcinogenic to humans," a designation that has further fueled scrutiny over its use.
Despite the allegations, J&J has consistently maintained that there is no scientific evidence linking talc to cancer. Nevertheless, the company made the decision to discontinue the sale of talc-based baby powder in the United States in 2020 and globally in 2023, reflecting the increasing public concern and legal challenges surrounding the product.
The legal battle over talc has been ongoing for years, with a notable case in 2016 when a jury ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer. Although this verdict was overturned a year later, it marked the beginning of a wave of similar claims against the company. Since then, various juries across the United States have ruled in favor of plaintiffs, leading to a growing number of lawsuits.
Erik Haas, J&J’s head of litigation, expressed that the settlement agreement allows the company to "put this matter behind it." The resolution has been welcomed by attorneys representing the plaintiffs, who view it as a positive conclusion to a protracted legal struggle that has lasted over a decade.
It is important to note that this settlement does not extend to the United Kingdom, where a separate and significant product liability case is currently in progress. This case, which is considered the largest of its kind in UK history, involves over 7,000 potential claimants and was filed in October 2025. The plaintiffs allege that J&J was aware of the cancer risks associated with its talc products, particularly concerning ovarian cancer and mesothelioma, yet continued to market and sell the product. J&J has denied these allegations, and the case is presently being adjudicated in the UK High Court.
As the settlement unfolds, it remains to be seen how it will impact the ongoing legal landscape surrounding talc products and the broader implications for consumer safety and corporate responsibility.